These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 14117027)
1. [ON THE TREATMENT OF STUTTERING WITH METHYLPENTYNOL (SUBCORTICALUM). STUDIES ON SCHOOL CHILDREN WITH SPEECH DISORDERS]. HABERMANN G Arch Ohren Nasen Kehlkopfheilkd; 1963 Dec; 182():680-4. PubMed ID: 14117027 [No Abstract] [Full Text] [Related]
2. [CONTRIBUTIONS TO MODERN VIEWS ON AND TREATMENT OF STUTTERING]. HANICKE O; LEBEN R Dtsch Gesundheitsw; 1964 Mar; 19():545-9. PubMed ID: 14184829 [No Abstract] [Full Text] [Related]
3. The effect of methylpentynol in man. DICKER SE; STEINBERG H Br J Pharmacol Chemother; 1957 Dec; 12(4):479-83. PubMed ID: 13489178 [TBL] [Abstract][Full Text] [Related]
4. The effect of methylpentynol and methylpentynol carbamate on the perfused superior cervical ganglion of the cat. MARLEY E; PATON WD Br J Pharmacol Chemother; 1959 Jun; 14(2):303-6. PubMed ID: 13662591 [TBL] [Abstract][Full Text] [Related]
5. [On the possibility or necessity of medical treatment of stuttering]. GUTZMANN H Dtsch Med J; 1962 Aug; 13():467-9. PubMed ID: 13903217 [No Abstract] [Full Text] [Related]
6. [The effect of methylpentynol (dalgol) in neurotic students in puberty]. LINKA Z Orv Hetil; 1962 Jan; 103():71-4. PubMed ID: 14465602 [No Abstract] [Full Text] [Related]
7. Susceptibility to methylpentynol and methylpentynol carbamate. MARLEY E Br Med J; 1958 Aug; 2(5094):493. PubMed ID: 13560914 [No Abstract] [Full Text] [Related]
8. Distribution of methylpentynol and methylpentynol carbamate in human body fluids. BARTHOLOMEW AA; BOURNE GL; MARLEY E Clin Sci; 1958 Nov; 17(4):629-37. PubMed ID: 13608973 [No Abstract] [Full Text] [Related]
9. Pharmacology of methylpentynol and methylpentynol carbamate. MARLEY E Br J Pharmacol Chemother; 1959 Jun; 14(2):284-302. PubMed ID: 13662590 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility to methylpentynol: personality and other variables. BARTHOLOMEW AA; MARLEY E J Ment Sci; 1959 Oct; 105():957-70. PubMed ID: 13797240 [No Abstract] [Full Text] [Related]
11. Methylpentynol. GLATT MM Med World; 1956 Mar; 84(3):214-7. PubMed ID: 13308623 [No Abstract] [Full Text] [Related]
13. Recovery after overdosage with methylpentynol. BROWN IM; ELLIS RA Br Med J; 1955 Jan; 1(4908):268-9. PubMed ID: 13219401 [No Abstract] [Full Text] [Related]
14. The electroencephalographic effects of methylpentynol. KENNEDY WA; MARLEY E Electroencephalogr Clin Neurophysiol; 1959 Feb; 11(1):59-64. PubMed ID: 13630232 [No Abstract] [Full Text] [Related]
15. A short survey of methylpentynol. LAPPER J J R Army Med Corps; 1956 Jan; 102(1):77-81. PubMed ID: 13307654 [No Abstract] [Full Text] [Related]
17. Toxic effects and side-effects of methylpentynol. CHAMBERS JS; MARLEY E Br Med J; 1956 Dec; 2(5007):1467-70. PubMed ID: 13374359 [No Abstract] [Full Text] [Related]
18. A controlled clinical trial of methylpentynol (oblivon). BOCKNER S J Ment Sci; 1957 Jan; 103(430):218-21. PubMed ID: 13416860 [No Abstract] [Full Text] [Related]
19. A controlled factorial trial of the use of methylpentynol in the short-term reduction of anxiety during electro-encephalographic examination. Ward B; Parsonage MJ Acta Psychiatr Scand; 1961; 37(4):331-5. PubMed ID: 14004917 [No Abstract] [Full Text] [Related]
20. Clinical aspects of susceptibility to methylpentynol. MARLEY E; BARTHOLOMEW AA J Neurol Neurosurg Psychiatry; 1958 May; 21(2):129-40. PubMed ID: 13539654 [No Abstract] [Full Text] [Related] [Next] [New Search]